Clinical trial
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
NCT00057759 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00057759 |
|---|---|
| Title | Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer |
| Official title | Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Sexual Dysfunction, Sexuality and Reproductive Issues |
| Intervention type | Drug, Other |
| Interventions | sildenafil citrate, Placebo |
| Enrollment | 115 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2006 |
| First posted | Apr 9, 2003 |
| Last update posted | Nov 17, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: